Sodium Reduction Ingredients Market to Exceed USD 18 Billion by 2032, Supported by Regulatory Initiatives and Clean-Label Trends

Sodium Reduction Ingredients Product Scope

Sodium reduction ingredients refer to a variety of compounds and additives used in food processing to reduce the sodium content of foods without compromising taste or texture. These ingredients include potassium chloride, sea salt alternatives, flavor enhancers like monosodium glutamate (MSG), and other flavor modifiers that mimic salty tastes. The primary goal of sodium reduction ingredients is to address health concerns associated with high sodium intake, such as hypertension and cardiovascular diseases, by lowering the overall sodium content in processed foods. Manufacturers use these ingredients strategically to maintain palatability while adhering to regulatory guidelines and consumer demand for healthier food options. Sodium reduction ingredients are increasingly utilized across the food industry, from packaged goods to restaurant menus, to help consumers manage their sodium intake without sacrificing flavor.

Sodium Reduction Political and Key Facts

The World Health Organization estimates that achieving its global 30% sodium intake reduction target could avert an estimated 7 million deaths globally by 2030. In response, over 80 countries have now implemented national sodium reduction strategies, creating a vast, policy-driven addressable market. However, the regulatory landscape presents a significant cost barrier. Navigating a single major market approval for a novel food ingredient like an SRI can require an investment of USD 250,000 to over USD 2 million and take 1.5 to 3.5 years, with no guarantee of success. This fragmentation is stark: while potassium chloride is widely used in the US and EU, its adoption in markets like Japan is limited by stricter regulatory perspectives, forcing multinational food companies to manage multiple, costly reformulation projects.

In countries with implemented front-of-pack warning labels (FOPL), such as Chile and Israel, studies show a 5-25% reduction in the sales of high-sodium staple products, compelling immediate industry reformulation. The looming threat of sodium taxes—modeled on the effectiveness of sugar taxes, which in some jurisdictions reduced targeted product sales by over 10%—adds further urgency. Concurrently, the political push for "clean labels" shapes formulation choices, with the market for "natural" label-friendly SRIs like mineral blends and yeast extracts growing at a CAGR approximately 2-3 percentage points higher than that of synthetic alternatives.

Key facts

• Almost all populations are consuming too much sodium.
• The global mean intake of adults is 4310 mg/day sodium (equivalent to 10.78 g/day salt). This is more than double the World Health Organization recommendation for adults of less than 2000 mg/day sodium (equivalent to < 5 g/day salt, or approximately one teaspoon).
• The primary health effect associated with diets high in sodium is raised blood pressure which increases the risk of cardiovascular diseases, gastric cancer, obesity, osteoporosis, Meniere’s disease, and kidney disease.
• An estimated 1.89 million deaths each year are associated with consuming too much sodium.
• Reducing sodium intake is one of the most cost-effective measures to improve health and reduce the burden of non-communicable diseases: for every US$ 1 invested in scaling up sodium reduction interventions, there will be a return of at least US$ 12.

Average Sodium Intake Per Country

Source:WHO and DIResearch, 2026

Public health authorities agree that chronic excess sodium intake can increase blood pressure levels and the risk for heart attack and stroke. High blood pressure contributes to the development of cardiovascular disease, the leading cause of death across the globe according to the World Health Organization (WHO). It is estimated that 2.5 million deaths could be prevented each year if global salt consumption were reduced to the recommended level. Sodium intakes around the world are well in excess of physiological need (10-20 mmol/day or 230- 460 mg/day of sodium).The WHO recommendations indicate that to prevent chronic diseases, an adult daily upper limit intake of sodium, should be less than 87 mmol/day (2,000 mg/day) or 5 g/day of salt (about one teaspoon) for adults to help reduce blood pressure and risk of cardiovascular disease, stroke, and coronary heart attack. The current average sodium intake in many countries is greater than 3,500 mg/day.

Snacking giant PepsiCo is aiming for at least 75% of its global convenient foods portfolio volume to meet or be below category sodium targets by 2030.

Global Sodium Reduction Ingredients Market Size and Forecast Analysis

According to DIResearch, in 2025, the global Sodium Reduction Ingredients market reached USD 12,384 million and is projected to grow to USD 18,443 million by 2032, reflecting a CAGR of approximately 5.85% between 2025 and 2032. Historically, the market expanded from USD 7,443 million in 2020 to USD 12,384 million in 2025, corresponding to a strong CAGR of around 12%. Growth moderated slightly in 2023–2024 following rapid post-pandemic reformulation efforts, but the long-term outlook remains positive, with the forecast period of 2026–2032 expecting an increase from roughly USD 13,103 million to USD 18,443 million, implying a CAGR of about 5.8–6.0%.

Source: Expert Interviews and DIResearch, 2026

Global Sodium Reduction Ingredients Market Competitive Landscape

The sodium reduction ingredients market shows a clear concentration around a limited number of leading companies, particularly in the MSG and yeast extract segments, where revenue scale strongly differentiates market leaders from smaller players. In monosodium glutamate–based solutions, Ajinomoto, Fufeng Group, and Meihua Holdings Group form a highly concentrated competitive core. By 2024, Ajinomoto and Fufeng each generated close to or above US$1.5 billion in sodium-reduction-related revenues, far exceeding other participants in this category. Their scale, global customer reach, and long-established production capabilities create high entry barriers and reinforce dominance in mainstream sodium reduction applications.

In the yeast extracts segment, market concentration is also rising, led by Biospringer and Angel Yeast, followed by Kerry Group, Givaudan, Corbion, and Lallemand. Biospringer’s revenue increased sharply from US$615 million in 2020 to over US$1.35 billion in 2024, positioning it as a clear leader within this segment. Angel Yeast more than doubled its revenue over the same period, strengthening its role as a major global supplier. While several multinational ingredient companies remain active, the revenue gap between the top two to three players and the rest highlights an increasingly concentrated competitive structure driven by technology, fermentation know-how, and application expertise.

Source: Above companies, Secondary Sources, Expert Interviews and DIResearch, 2026

For details, please refer to the report "Global Sodium Reduction Ingredients Competitive Landscape Professional Research Report 2026"

Global Key Manufacturers of Sodium Reduction Ingredients Include:

Ajinomoto

Fufeng Group

Biospringer

Meihua Holdings Group

Angel Yeast Co., Ltd

Kerry Group

ABF

Givaudan

Lotus Health Group Company

Lallemand

Corbion

Cargill

Biorigin

China National Salt Industry Corporation

Morton Salt

Snowsky Salt Industry Group

Jiang Su Suyan Jingshen Co., Ltd

Yunnan Salt & Salt Chemical Industry Co., Ltd

Sodium Reduction Ingredients Product Segment Include:

Monosodium Glutamate

Yeast Extracts

Mineral Salt Blends

Others

Sodium Reduction Ingredients Product Application Include:

Snack Foods

Dairy and Bakery

Sauces and Seasonings

Meat Products

Others